The TROIA (TEE-Guided Thrombolytic Regimens for Prosthetic Valve Thrombosis) trial observed that low-dose (25 mg) slow infusion of tPA over 6 hours, repeated as needed, provided a safe and effective treatment option for patients with prosthetic valve thrombosis. 9 This evidence concerns the gene PLAT and deep vein thrombosis.